Atossa Therapeutics, Inc.ATOSNASDAQ
Loading
EPS Growth Recovery in ProgressRecovering
Percentile Rank64
3Y CAGR-43.2%
5Y CAGR-23.4%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
-43.2%/yr
vs +12.0%/yr prior
5Y CAGR
-23.4%/yr
Recent deceleration
Acceleration
-55.2pp
Decelerating
Percentile
P64
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
2 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2024 | 16.67% |
| 2023 | -14.29% |
| 2022 | -16.67% |
| 2021 | 90.86% |
| 2020 | 2.96% |
| 2019 | 63.09% |
| 2018 | 49.86% |
| 2017 | 57.69% |
| 2016 | 72.86% |
| 2015 | 12.96% |